Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure
Top Things to Know: Role of Biomarkers for the Prevention, Assessment, and Management of HF
2016 Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 Guideline for the Management of Heart Failure
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies
Drugs That May Cause or Exacerbate Heart Failure
